Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
PubMed laboratory research record [PMID: 41026893] PubMed record related to this compound for laboratory literature review
229 REWIND (around 9,900 participants, approximately one third with established CVD, median 5.4 years) demonstrated dulaglutide lowered major adverse cardiovascular event risk compared with placebo (HR 0.88
GLP-1RAs inhibit RGC apoptosis in glaucoma through GABAergic signaling, but their role in AMD, characterized by oxidative stress and choroidal neovascularization, needs further investigation ( The latest diabetic retinopathy preferred practice guidelines from the American Academy of Ophthalmology indicate that the rising use of GLP-1RAs may lead to quick glycemic control and severe hypoglycemia and has been reported to cause higher rates of retinopathy complications, especially in patients with early-stage DR ( 4.2 Delivery optimization Systemic administration of GLP-1RAs reduces their availability in the retina and can lead to off-target effects, particularly gastrointestinal issues
Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions
2013;98(2):E291E300.
Such drugs may not be compounded even if they appear on the FDA drug shortage list
US$ 28.37
US$ 23.45
US$ 23.28
US$ 24.84
US$ 28.66
US$ 28.02
